In our ketamine-assisted therapy, ketamine can be administered either by drinking it (in a liquid solution) or having it injected into the gluteal muscle. In medical terms, you can receive ketamine either orally (by drinking) or as an intramuscular (IM) injection. The most suitable route of administration is always agreed on between the doctor and the client individually.

In both cases, the medicinal product administered is Calypsol, approved by the State Institute of Mental Health (more about the drug on the Institute’s website). When given orally, the client receives 200–350 mg of the substance. When administered by IM injection, the dose is 0.2–1.5 mg/kg.

The medicinal product Calypsol (containing the active substance ketamine) is approved primarily as an anesthetic and analgesic; however, physicians worldwide commonly use it to treat depression and other ailments. In psychiatric indications, it is currently used off-label. This means that the drug may be used for indications other than its primary purpose (in the Czech Republic, this is only general anesthesia and analgesia in the case of ketamine). Such use is regulated by law and is permitted based on comprehensive scientific evidence for each individual indication.

The medicinal product Calypsol (containing the active substance ketamine) is approved primarily as an anesthetic and analgesic; however, physicians worldwide commonly use it to treat depression and other ailments. In psychiatric indications, it is currently used off-label. This means that the drug may be used for indications other than its primary purpose (in the Czech Republic, this is only general anesthesia and analgesia in the case of ketamine). Such use is regulated by law and is permitted based on comprehensive scientific evidence for each individual indication.